- August 22, 2014
IMGM Laboratories GmbH announces the appointment of Dr. Michael Bonin as Managing Director
- November 12, 2013
New Microarray for Identifying and Subtyping Pathogenic E. coli Using Unique DNA Signatures
- August 12, 2013
Drei Millionen Euro für die Entwicklung von Impfschutz gegen Zeckenbisse
Post-processing note • reasons for outsourcing NextGen services
- Investment costs in equipment can be prohibitive and continuous state-of-the-art hard- and software updating for new products and technologies is also expensive. Lab personnel have to be well-trained to ensure error minimization and apparatus feeds have to proceed regularly.
- An external service provider can offer experience from a lot of different projects, particularly in establishing a strong quality management system for diagnostic and pharmaceutical needs.
In short, building up your own microarray service unit makes sense only in special cases -- for example, research projects with a considerable proportion of customized needs and pharmaceutical projects where issues of confidentiality are paramount.